Mortality rate and prognostic factors for dogs with severe anaphylaxis: 67 cases (2016–2018)

M. Ryan Smith 1Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by M. Ryan Smith in
Current site
Google Scholar
PubMed
Close
 DVM
,
Virginie A. Wurlod 1Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Virginie A. Wurlod in
Current site
Google Scholar
PubMed
Close
 MS, Dr Med Vet
,
Alan G. Ralph 2MedVet Medical and Cancer Centers for Pets, Mandeville, LA 70448.

Search for other papers by Alan G. Ralph in
Current site
Google Scholar
PubMed
Close
 DVM
,
Erin R. Daniels 2MedVet Medical and Cancer Centers for Pets, Mandeville, LA 70448.

Search for other papers by Erin R. Daniels in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Mark Mitchell 1Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Mark Mitchell in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
Restricted access
Purchase Article

Abstract

OBJECTIVE

To determine mortality rates for dogs with severe anaphylaxis and identify potential prognostic factors.

ANIMALS

67 dogs with suspected anaphylaxis graded as severe.

PROCEDURES

Dogs were classified on the basis of outcome as survivors and nonsurvivors. Medical records were reviewed, and data were extracted including signalment, examination findings, time to hospital admission from onset of clinical signs, CBC results, serum biochemical analysis results, coagulation testing results, and findings on abdominal ultrasonography. Initial treatment within the first 6 hours after hospital admission was recorded for analysis, specifically including the use of epinephrine, diphenhydramine, corticosteroids, antimicrobials, fresh-frozen plasma, and supplemental dextrose.

RESULTS

The overall mortality rate was 14.9% (10/67) for dogs with anaphylaxis graded as severe. Serum phosphorus concentration and prothrombin time (PT) were significantly higher in nonsurvivors, compared with survivors. Nonsurvivors had lower presenting body temperatures than survivors. Serum phosphorus concentration ≥ 12.0 mmol/L, hypoglycemia within 6 hours after hospital admission, high PT value, concurrently high PT and partial thromboplastin time (PTT) values > 50% above the reference range limit, and the need for supplemental dextrose were associated with death. The incidences of coagulopathy and peritoneal effusion were unexpectedly high (85.2% and 65.5% of dogs, respectively) but were not indicative of survival.

CONCLUSIONS AND CLINICAL RELEVANCE

Despite the poor presenting clinical condition seen in dogs with severe anaphylaxis, the rate of survival with treatment was fairly high. Coagulopathy and the presence of peritoneal effusion were common findings in dogs with severe anaphylaxis. Serum phosphorus concentration ≥ 12.0 mmol/L, high PT value, concurrent increases of PT and PTT values > 50% above reference range limits, hypoglycemia within 6 hours after hospital admission, and the need for supplemental dextrose were associated with death.

All Time Past Year Past 30 Days
Abstract Views 1409 0 0
Full Text Views 5072 2350 214
PDF Downloads 4089 1690 177
Advertisement